We are live on ! Find out more
NTGN

Neon Therapeutics, Inc. Common Stock
NTGN

Delisted

NTGN was delisted on the 5th of May, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Neon Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 43 → 0 (-43)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $39.9M → $0 (-$39.9M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 43

Holders
–
Holders Change
-43
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
43
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$25.7M
2
AC
Armistice Capital
New York
-$2.77M
3
BlackRock
BlackRock
New York
-$2.18M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.9M
5
AC
Athanor Capital
New York
-$1.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
– -$36K -13,771 Closed
AIG
27
American International Group
New York
– -$22K -8,489 Closed
PAM
28
Panagora Asset Management
Massachusetts
– -$16K -6,029 Closed
MAM
29
Meeder Asset Management
Ohio
– -$15K -5,878 Closed
Victory Capital Management
30
Victory Capital Management
Texas
– -$12K -4,896 Closed
Barclays
31
Barclays
United Kingdom
– -$13K -4,749 Closed
JP Morgan Chase
32
JP Morgan Chase
New York
– -$12K -4,535 Closed
BNP Paribas Financial Markets
33
BNP Paribas Financial Markets
France
– -$11.7K -4,425 Closed
Citigroup
34
Citigroup
New York
– -$11K -4,010 Closed
SO
35
STRS Ohio
Ohio
– -$4K -1,800 Closed
Legal & General Group
36
Legal & General Group
United Kingdom
– -$4K -1,691 Closed
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
– -$4K -1,500 Closed
Rockefeller Capital Management
38
Rockefeller Capital Management
New York
– -$3K -1,000 Closed
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
– -$2K -770 Closed
JCM
40
Jacobi Capital Management
Pennsylvania
– -$1K -500 Closed
AIP
41
Ameritas Investment Partners
Nebraska
– -$1K -485 Closed
1
2

NTGN Hedge Fund Activity: Q2 2020 in Review

0 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Neon Therapeutics, Inc. Common Stock (NTGN) for Q2 2020, worth a combined $0 — down 100% from $39.9M a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of NTGN and 0 opened new positions — a net loss of 43 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was TRV GP III, exiting entirely with an estimated $25.7M sold.

  • 0 institutional investors held Neon Therapeutics, Inc. Common Stock (NTGN) as of Q2 2020, down from 43 in Q1 2020.
  • Funds reported $0 of Neon Therapeutics, Inc. Common Stock stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Neon Therapeutics, Inc. Common Stock positions in Q2 2020 and 43 closed out, a net change of -43 holders.
  • The largest Neon Therapeutics, Inc. Common Stock seller in Q2 2020 was TRV GP III, an estimated $25.7M sold.

Based on aggregated 13F filings for Q2 2020.